Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01352260 · ClinicalTrials.gov registry record
Near-Infrared Spectroscopy Comparison Study
A clinical trial, sponsored by Nonin Medical.
- Completed
- Registry status
- 17
- Enrollment target
NCT01352260: Completed study, sponsored by Nonin Medical.
NCT01352260 is a clinical trial that has completed, run by Nonin Medical. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01352260 has completed, sponsored by Nonin Medical.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The objective of this study is to validate Near-Infrared (NIRS) monitoring in patients undergoing circulatory arrest. This study will compare two-wavelength NIRS INVOS System, Somanetics; Troy, MI) with four-wavelength NIRS (Nonin Medical, Inc; Plymouth, MN) to determine which modality best correlates with jugular venous oxygen saturation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-04 |
What the finished NCT01352260 record still lists
NCT01352260 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01352260 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01352260 about?
NCT01352260 is a clinical study titled "Near-Infrared Spectroscopy Comparison Study". The objective of this study is to validate Near-Infrared (NIRS) monitoring in patients undergoing circulatory arrest. This study will compare two-wavelength NIRS INVOS System, Somanetics; Troy, MI) with four-wavelength NIRS (Nonin Medical, Inc; Plymouth, MN) to determine which modality best correlat...
What is the current status of trial NCT01352260?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2011-05. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT01352260?
This trial is sponsored by Nonin Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia